SHIONOGI & CO LTD 4
4 · ENANTA PHARMACEUTICALS INC · Filed Mar 28, 2013
Insider Transaction Report
Form 4
SHIONOGI & CO LTD
10% Owner
Transactions
- Conversion
Common Stock
2013-03-26+1,599,760→ 1,599,760 total - Conversion
Series F Convertible Preferred Stock
2013-03-26−6,894,966→ 0 total→ Common Stock (1,599,760 underlying)
Footnotes (1)
- [F1]The Series F Convertible Preferred Stock has no expiration date, and each share of Series F Convertible Preferred Stock converted automatically into approximately 0.23202 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration.